Study of the possibility for applying of porous silicon nanopowders as a system for the targeted drug delivery of “vinpocetine”


Nowadays diagnostics and treatment of disorder of the cognitive functions is one of the most intensively studied areas of the modern neurology. Vinpocetine is one of the widely used medicinal preparations for the treatment of such kind of diseases [1]. Presently vinpocetine is produced in the form of pellets containing 5 and 10 mg of the drug. Such drug dosage form proves to be rather efficient but it does not provide the desired prolonged effect.

Therefore, now an actual problem is the elaboration of stable and biocompatioble drug dosage forms with the delayed release of vinpocetine.

One of the prospective ways for solution of this problem is the development of systems for the targeted drug delivery based on silicon nanoparticles including those ones obtained from porous silicon. It is well known that these systems are biocompatible and biodegradable [0, 0].

Aim of the Research. The purpose of this work is the elaboration of vinpocetine delivery system on the basis of porous silicon and the study of efficiency of the processes concerned with adsorption and desorption of the medicinal preparation in this system.

Materials and methods

Porous silicon nanopowder was obtained according to a standard procedure using electrochemical etching of silicon in the alcoholic solution of fluoric acid, followed by ultrasonic grinding. Specific surface area of the porous silicon nanopowder was of ~ 60 m2/g. Some features in morphology and composition of the particles used in the work are presented in [0].

The obtained nanopowder was submerged into 5%-solution of vinpocetine (ND 42-9175-03) for 20 and 60 minutes. Adsorption of the drug onto porous silicon was controlled by IR-spectroscopy method with the use of VERTEX 70 Bruker spectrometer. Kinetics of vinpocetine release from the nanoparticles into 0,1 M solution of hydrochloric acid was determined at the temperature of 37 ± 0,5 °C. The volume of dissolution medium was of 100 ml. Dialysate tests (5 ml) were sampled after strictly determined intervals of time (15, 30, 45, 60, 90, 120 minutes). Required amount of medium was supplied with the same solvent. In order to determine vinpocetine content spectrophotometric method in the UV-spectral range (314±2 nm) was applied. Concentration of the analyzed substance was determined by the calibration plot. Producing of vinpocetine microcapsules with the shells made of gelatin, ethylcellulose and sodium alginate as well as the procedure of biopharmaceutical investigations for these drug forms can be found in [0].

Results and discussions

Comparative analysis of IR-transmission spectra for nanopowders of porous silicon in the range of 400-4000 cm-1 after deposition of the drug with those ones of the primary powder of porous silicon and vinpocetine substance demonstrated the presence of the bands characteristic of the medicinal preparation in the samples (absorption bands at 1720, 1680 and 1607 cm-1). Note that composition of the porous silicon particles according to IR-spectroscopy data did not considerably change [0].

Data on the degree of vinpocetine release out of the different drug delivery systems are presented in Table 1.

Table 1 - Degree of release for vinpocetine from the different drug delivery systems




Microcapsules of ethylcellulose

32% and 70%

1 and 6 hours, resp-ly

Microcapsules of gelatin

60% and 94%

1 and 6 hours, resp-ly

Microcapsules of sodium alginate


2 hours

Nanoparticles of porous silicon

9,8% and 60%

1 and 6 hours, resp-ly

Our investigations demonstrated that the release of vinpocetine from Si nanoparticles was of 60% for 6 hours of the experiment that is comparable with the degree of vinpocetine release from microcapsulated forms (70% and 94% from microcapsules with the shells of ethylcellulose and gelatin, respectively).


The performed study showed a possibility of using porous silicon as an agent of prolonged vinpocetine delivery and significance of the further pharmacologic investigations of this system.

List of literature

Szakacs T., Veres Z and Vereczkey L. Vinpocetine is extensively metabolized in rats, dogs and humans, and the plasma clearance approximates the hepatic plasma flow in each of the species. Pol. J. Pharmacol. 2001 53 623. Ksenofontova O I, Vasin A. V., Egorov V. V. Porous silicon and its application in biology and medicine. Technical Physics. 2014. 84 1 67

Canham L 2014 Handbook of Porous Silicon (Springer) 1017 p

Lenshin A S, Kashkarov V M. The composition and reactivity of nanopowders porous silicon. Inorganic materials. 2012. 48 10 1091.

Polkovnikova Yu. A. Investigations on the development of encapsulated dosage form of vinpocetine. Russian Journal of Biopharmaceuticals. 2015. 7 4 10.

Polkovnikova Yu. A., Stepanova E. F. Experimental substantiation of technological parameters of afobazole of microencapsulation by the method of mathematical planning // Herald of the Voronezh state University. Series: Chemistry. Biology. Pharmacy. 2014. №. 2. S. 121-124.

Year: 2016
City: Shymkent
Category: Medicine